AMZN
Amazon.com, Inc.
AMZN's fundamentals are mixed: revenue grew 15%, but free cash flow turned negative. Its PE of 22x looks cheaper than it really is, because one-off gains boosted its recent earnings. Analysts expect strong earnings growth.
GEF-B
Greif, Inc.
There isn't enough reported data to score GEF-B yet.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
GEF-B Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Healthy | |
| Unavailable | |
| Under pressure |
GEF-B's profitability is currently healthy, but its revenue and balance sheet are under pressure. There isn't enough data to rate its cash flow.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
GEF-B PE Valuation
GEF-B has no meaningful PE right now: it lost money over the past year.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
AMZN has the edge over GEF-B on the outlook, with more favorable revenue expectations.
GEF-B Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect GEF-B's earnings to grow and its profitability to improve, with its revenue holding steady.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN's earnings per share have climbed steadily: $12.37 over the past year, up 75% from the year before, and higher year over year for 14 quarters in a row. Its recent earnings include one-off gains.
GEF-B Earnings Per Share
GEF-B and AMZN do not have enough comparable growth data to identify a winner.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over GEF-B on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over GEF-B on profitability, with a higher operating margin.
GEF-B Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $1.2B | +2.7% |
| Q1 2026 | $1.1B | -23% |
| Q4 2025 | $994.8M | -21% |
| Q3 2025 | $701.3M | -51% |
| Q3 2025 | $1.1B | -22% |
| Q2 2025 | $1.4B | +1.1% |
| Q1 2025 | $1.3B | +5% |
| Q4 2024 | $1.4B | +8.3% |
GEF-B's revenue has slid since its 2022 peak: $1.2B last quarter, up 2.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 9.3% | +2.8 points |
| Q1 2026 | 3.3% | -5.3 points |
| Q4 2025 | 26% | +21 points |
| Q3 2025 | 0.7% | -8.2 points |
| Q3 2025 | 6.4% | -5.3 points |
| Q2 2025 | 8.6% | +1.4 points |
| Q1 2025 | 4.7% | -1 points |
| Q4 2024 | 8.9% | +0.3 points |
GEF-B's operating margin was 9.3% last quarter, up 2.8 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
GEF-B Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $49.1M | -69% |
| Q1 2026 | $59.8M | -44% |
| Q4 2025 | -$57.4M | +$9.1M |
| Q3 2025 | $156.9M | +390% |
| Q2 2025 | $106.4M | +129% |
| Q1 2025 | -$66.5M | -$15.4M |
| Q4 2024 | $142.1M | +13% |
| Q3 2024 | $32M | -80% |
GEF-B has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
GEF-B Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +32K shares |
| 1 year | -2.8% | -1.3M shares |
| 3 years | -1.4% | -637K shares |
| 5 years | -4.9% | -2.4M shares |
| Available history | -4.4% | -2.1M shares |
GEF-B has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $2.9M |
| Q1 2026 | $19.1M |
| Q4 2025 | $128.1M |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
GEF-B Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | 3.8x | Elevated |
| Q2 2025 | 3.4x | Elevated |
| Q1 2025 | 3.7x | Elevated |
| Q4 2024 | 3.5x | Elevated |
| Q3 2024 | 3.9x | Elevated |
| Q2 2024 | 4.0x | Elevated |
| Q1 2024 | 2.8x | Moderate |
| Q4 2023 | 2.4x | Moderate |
GEF-B's net debt is about 3.8 years of its operating earnings (EBITDA), about the same as a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
GEF-B Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.7 | Neutral |
| Stochastic | 33.8 | Neutral |
GEF-B's weekly RSI is 49 (neutral) and its Stochastic is 34 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
GEF-B PE vs Consumer Cyclical Sector
| Metric | GEF-B | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
GEF-B has no meaningful PE right now: it lost money over the past year.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over GEF-B on trend strength, trading above more of its moving averages.
GEF-B Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $108.2 | 7.6% below |
| 20 week MA | $105.4 | 5.2% below |
| 50 week MA | $91.8 | 8.8% above |
| 100 week MA | $77.7 | 29% above |
| 200 week MA | $73.8 | 35% above |
GEF-B has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 35% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
GEF-B Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.6 | $48.8 | -5.4% |
| 2021 | $48.8 | $57.4 | +18% |
| 2022 | $57.4 | $77.1 | +34% |
| 2023 | $77.1 | $66.0 | -14% |
| 2024 | $66.0 | $68.6 | +3.9% |
| 2025 | $68.6 | $75.8 | +10% |
| 2026 YTD | $75.8 | $99.9 | +32% |
GEF-B has the edge over AMZN on returns for 2026, with the stronger performance.